Want to join the conversation?
$ABBV 2Q15 Call: Adjusted earnings per share of a dollar $0.08, representing a growth of more than 31% vs. 2Q14. Our results included strong operational sales growth of nearly 20% driven by a number of products across our portfolio, including strong performance from our newly acquired oncology therapy Imbruvica.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.